Breast Neoplasms: all 12,820 studies
Page 123 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Accelerated Radiotherapy Outcomes in WomenCompletedNCT00156130
- Hypofractionated Radiotherapy Post-Lumpectomy in Women With Node Negative Breast CancerCompletedNCT00156052Not applicable
- Randomized Trial of Follow-up Strategies in Breast CancerCompletedNCT00156039Phase 4
- Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast CancerCompletedNCT00155259Phase 2
- Proton Magnetic Resonance Spectroscopy of Normal Breast Tissues in Women VolunteersStatus unknownNCT00155090
- Imaging Characteristics of Breast Cancer in Women Under 40 Years of AgeStatus unknownNCT00155038
- Paclitaxel (Phyxol) and Cisplatin as First-line Chemotherapy for Metastatic Breast CancerStatus unknownNCT00154882Phase 2
- Navelbine and Capecitabine in the Treatment of Metastatic Breast CancerCompletedNCT00153907Phase 1
- Effects of Exercise Intervention on Insulin Levels in Breast Cancer SurvivorsCompletedNCT00153894Not applicable
- An Observational Study of Current Practice Pattern on the Treatment of Women With Metastatic Breast Cancer Whose Tumors Overexpress Her2neuCompletedNCT00153218
- A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)CompletedNCT00152191Phase 3
- The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)CompletedNCT00152178Phase 3
- RCT of a Group Intervention for Women With a Family History of Breast CancerCompletedNCT00150917Phase 3
- Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)CompletedNCT00148902Phase 1
- TBP Study With Capecitabine Plus Minus TrastuzumabCompletedNCT00148876Phase 3
- Capecitabine in Women With Operable Breast CancerTerminatedNCT00148720Phase 2
- Study of Xyotax (CT-2103) in Patients With Metastatic Breast CancerCompletedNCT00148707Phase 2
- Preoperative Cisplatin in Early Stage Breast CancerCompletedNCT00148694Phase 2
- Preoperative Herceptin and Navelbine for Breast CancerCompletedNCT00148681Phase 2
- Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast CancerCompletedNCT00148070Phase 2
- Diet and Breast Cancer Prevention TrialCompletedNCT00148057Phase 3
- MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.TerminatedNCT00147550Phase 1/2
- Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast CancerCompletedNCT00146601Phase 2
- Cytoxan, Epirubicin and Capecitabine in Women With Breast CancerCompletedNCT00146588Not applicable
- Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast CancerCompletedNCT00146562Phase 2
- Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast CancerCompletedNCT00146549Phase 3
- Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional BiopsyCompletedNCT00146536
- UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast CancerCompletedNCT00146042Phase 2
- Companion Pharmacogenetic Study to UMCC 9900/9901TerminatedNCT00146029
- Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast CancerCompletedNCT00145743Phase 1/2
- Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority CommunitiesCompletedNCT00145197Not applicable
- GF-GS 01: Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast CancerCompletedNCT00144898Phase 3
- Implementation of Quality of Life Diagnostics and TherapyCompletedNCT00141635
- Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast CancerCompletedNCT00140738Phase 1
- Boost Use in Breast Conservation RadiotherapyStatus unknownNCT00138814Phase 3
- Neoadjuvant Therapy With Herceptin and Taxol for Breast CancerCompletedNCT00136539Phase 2
- Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast CancerCompletedNCT00135018Phase 2
- Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBCCompletedNCT00134680Phase 2
- Neoadjuvant Herceptin in Patients With Breast CancerTerminatedNCT00133796Phase 2
- A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly PaclitaxelCompletedNCT00131963
- Effect of Lifestyle Factors and Hormone Function on Breast Density in Healthy Hispanic Women Who Are Undergoing Mammography for Breast Cancer ScreeningCompletedNCT00131950Not applicable
- High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone TherapyTerminatedNCT00131924Phase 2
- An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer TreatmentTerminatedNCT00131612
- Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With TrastuzumabTerminatedNCT00130507Phase 2
- Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone LesionsTerminatedNCT00130494Phase 3
- Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast CancerCompletedNCT00129922Phase 3
- Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer PatientsCompletedNCT00129896Phase 1/2
- Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer PatientsCompletedNCT00128856Phase 2
- Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer PatientsCompletedNCT00128843Phase 2
- Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer PatientsCompletedNCT00128778Phase 4
- Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic CancerCompletedNCT00128622Phase 1
- Sentinel Node Biopsy and Axillary Sampling in Operable Breast CancerTerminatedNCT00128362Phase 2
- Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer PatientsCompletedNCT00128310Phase 3
- Pamidronate Administration in Breast Cancer Patients With Bone MetastasesCompletedNCT00128297Phase 4
- Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their ConfidantsCompletedNCT00127465Phase 1/2
- A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)TerminatedNCT00126451Phase 2
- STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)Status unknownNCT00126360Phase 4
- A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast CancerCompletedNCT00124111Phase 2
- Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast CancerCompletedNCT00123929Phase 2
- Study of GPX-100 in the Treatment of Metastatic Breast CancerTerminatedNCT00123877Phase 2
- Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With RadiotherapyWithdrawnNCT00123812
- Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary DissectionTerminatedNCT00123799Phase 2
- Primary Progesterone Therapy for Operable Breast CancerCompletedNCT00123669Phase 2/3
- Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm AssessmentCompletedNCT00122356Phase 3
- Study of Motexafin Gadolinium and Docetaxel for Advanced CancerCompletedNCT00120939Phase 1
- Treatment for Patients Suffering From Anemia Due to ChemotherapyCompletedNCT00120692Phase 2
- Peer Counseling for Weight LossStatus unknownNCT00120029Not applicable
- Treatment for Elderly Patients With High Risk Breast CancerCompletedNCT00117910Phase 3
- Effects of Aerobic Exercise Versus Weight Training in Breast Cancer Survivors During ChemotherapyCompletedNCT00115713Phase 3
- Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast CancerCompletedNCT00115505
- Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)CompletedNCT00115414Phase 2
- Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast CancerCompletedNCT00114816Phase 3
- Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast CancerStatus unknownNCT00114296Not applicable
- Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast CancerTerminatedNCT00112749Phase 2
- Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast CancerCompletedNCT00111787Phase 2
- Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast CancerCompletedNCT00110695Phase 2
- Campath-1H + FK506 and Methylprednisolone for GVHDCompletedNCT00109993Phase 2
- PET Scans in Patients With Locally Advanced Breast CancerCompletedNCT00109785Phase 1
- A Study to Evaluate Erlotinib in Patients With Advanced or Metastatic Breast Cancer During or Following ChemotherapyCompletedNCT00109265Phase 2
- A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast CancerCompletedNCT00109239Phase 3
- Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast CancerCompletedNCT00107510Phase 2
- Radiation Therapy in Treating Women With Localized Breast CancerCompletedNCT00107497Not applicable
- Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast CancerCompletedNCT00107484Phase 2
- Trastuzumab and Capecitabine in Treating Women With Metastatic Breast CancerCompletedNCT00107393Phase 2
- Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast CancerCompletedNCT00107263Phase 3
- Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast CancerCompletedNCT00107094Phase 1
- Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal WomenCompletedNCT00107016Phase 2
- A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014)CompletedNCT00106145Phase 1
- Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast CancerCompletedNCT00105950Phase 2
- A Study of Patients With HER2-Positive Metastatic Breast CancerCompletedNCT00105456
- Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast CancerCompletedNCT00104702Phase 2
- Docetaxel in Treating Older Women With Metastatic Breast CancerTerminatedNCT00104624Phase 2
- Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast CancerCompletedNCT00103233Phase 3
- Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast CancerCompletedNCT00103181Not applicable
- A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast CancerTerminatedNCT00102895Phase 2
- A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast CancerCompletedNCT00102219Phase 2
- Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast CancerTerminatedNCT00101062Phase 2
- IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast CancerCompletedNCT00100893Phase 1
- Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast CancerCompletedNCT00100750Phase 1/2
- DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast CancerTerminatedNCT00099281Phase 3